Get to know us
Chief Executive Officer
Nikki Hafezi was funded by the US National Science Foundation to manage the IP portfolio and industrial relations of a biomedical research consortium involving CalTech, USC Los Angeles and UC Santa Cruz.
She has also been instrumental in creating and developing academic start-up companies and M&A in the field of ophthalmology. Mrs. Hafezi holds a Master’s degree in Intellectual Property from the Swiss Federal Institute of Technology.
In 2015, Nikki Hafezi was voted onto the “Top 40 under 40” global Powerlist of “The Ophthalmologist”. Mrs. Hafezi was one of six females listed, and one of two individuals representing industry.
Member of the board
Rolf Schwind owns and leads Schwind eye-tech solutions, one of the major excimer laser companies in ophthalmology.
He provides invaluable know-how and international managerial experience for high-tech medical device companies.
Chief Scientific and Medical Officer
Farhad Hafezi, MD, PhD, FARVO, is a Swiss professor, anterior segment surgeon, and ocular cell biologist. Since 2014, he was voted continuously onto the biennial PowerList100, a list of the 100 most influential people in ophthalmology.
Hafezi holds professorships at the University of Geneva, Switzerland, at USC Los Angeles and at the Medical University of Wenzhou, China.
Combining patient care, research & development, and teaching, Hafezi is a pioneer and KOL of corneal cross-linking (CXL). Hafezi’s work comprises over 185 peer-reviewed articles, letters, reviews and book chapters (7,900 citations, impact factor: 625, h index: 45).
For more information, visit his Wikipedia profile.